EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Intraductal papillary neoplasm of the bile duct

Hassan Aziz, Peyton Seda, Matthew Gosse, Yashant Aswani, Timothy M Pawlik

HPB · 2025-12 · 27 (12) · 1483-1488

DOI: 10.1016/j.hpb.2025.08.017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift HPB, 2025-12. Verfasst von Hassan Aziz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA. Electronic address: Hassan-Aziz@uiowa.edu. Hauptthemen laut MEDLINE: Bile Duct Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Intraductal papillary neoplasm of the bile duct (IPNB) was formally adopted in the 2010 WHO classification as a distinct clinical and pathological entity. We herein review the concept, clinical and pathologic features, as well as the prognosis of IPNB. METHODS: A comprehensive review was conducted using MEDLINE/PubMed, Google Scholar, Cochrane Library, and the Web of Science, which were accessed between 2004 and 2025. The main search focused on "Intraductal papillary neoplasm of the bile duct." RESULTS: IPNB often present with intermittent right upper quadrant abdominal pain, recurrent episodes of acute cholangitis, obstructive jaundice with macroscopic or microscopic mucin, and dilation of the proximal bile duct. On histology, IPNB is characterized by papillary proliferation of neoplastic biliary epithelial cells with delicate fibrovascular stalks within the bile duct. MRI, including MRCP, has the highest diagnostic sensitivity (65.5 %) followed by CT (50 %). Surgical resection with a negative margin is the treatment of choice. In contrast to flat intraductal neoplasia-associated cholangiocarcinoma, IPNB has a better prognosis and postoperative outcome with a 5-year survival of 70-81 % although risk of recurrence can be high. CONCLUSION: Clinicians need to be familiar with the presentation, diagnosis, and treatment of IPNB lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Duct NeoplasmsHumansPrognosis

Autor:innen und Institutionen

  • Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA. Electronic address: Hassan-Aziz@uiowa.edu.
  • Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Zitieren

APA

Aziz, H., Seda, P., Gosse, M., Aswani, Y., & Pawlik, T. M. (2025). Intraductal papillary neoplasm of the bile duct. HPB, 27(12), 1483-1488. https://doi.org/10.1016/j.hpb.2025.08.017

Vancouver

Aziz H, Seda P, Gosse M, Aswani Y, Pawlik TM. Intraductal papillary neoplasm of the bile duct. HPB. 2025;27(12):1483-1488. doi:10.1016/j.hpb.2025.08.017

BibTeX
@article{Aziz2025,
  author = {Aziz, Hassan and Seda, Peyton and Gosse, Matthew and Aswani, Yashant and Pawlik, Timothy M},
  title = {Intraductal papillary neoplasm of the bile duct},
  journal = {HPB},
  year = {2025},
  volume = {27},
  number = {12},
  pages = {1483--1488},
  doi = {10.1016/j.hpb.2025.08.017}
}
Kostenlos starten →